Mylan N.V. To Acquire Perrigo For $29B

April 12, 2015 | Mylan N.V. has made a $29 billion offer to acquire Irish pharmaceutical company Perrigo at $205 per share. Perrigo, which has two offices in Israel, will delist from the TASE and other stock markets if the deal goes through, with Perrigo being one of the more heavily-traded stocks on the TASE. Perrigo has been operating in Israel and on the TASE since it acquired Agis Pharmaceuticals in March 2005.